This Solicitation opportunity from Department Of Defense was posted on August 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

HYDROGEN PEROXIDE TOPI

Closed

SPE2DP-26-T-4574Federal

Submission Closed08/17/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Simethicone Tablets (USP) Supply

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Casualty Triage Tags (NSN 6515015871700)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Loratadine Tablets 10 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sterile Surgical Lubricant (NSN 6505016265774)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0206

Solicitation SPE2DP-27-T-0206 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 50 bottles of Hydrogen Peroxide Topical Solution, USP. The product is an over-the-counter topical solution for external use containing 3% stabilized hydrogen peroxide, with each unit of issue consisting of a 473 milliliter bottle. Delivery is required within 20 days of award to a destination in Washington DC. The procurement is governed by NAICS code 325412 and requires compliance with the Buy American and Balance of Payments Program for quotes exceeding the micro-purchase threshold. The contractor must adhere to strict quality and safety standards, including FDA regulations and the DLA Master List of Technical and Quality Requirements. Packaging and marking must comply with MIL-STD-2073-1E, Medical Marking Standard No. 1, and Special Packaging Instructions MPPWN00001. Because the item is classified as hazardous material, the contractor must provide a current Material Safety Data Sheet (MSDS) and ensure all labeling and shipping comply with 49 CFR, ICAO, and IMDG regulations. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0207

Solicitation SPE2DP-27-T-0207 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Simethicone Tablets, USP, 80 mg, chewable. The required product is an FDA-regulated drug provided in unit dose 100-count blister packs. Key technical specifications include a non-extendable shelf life of 36 months for Type I (Code Q) items. The contract requires delivery to the DC ARNG Med Det in Washington, DC, with a delivery window of 20 days after receipt of order and a required delivery date of November 2, 2026. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging data per MIL-STD-2073-1E. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting under DFARS 252.204-7012. Quotations must be submitted via the DIBBS portal by November 4, 2026, and the submission of a Safety Data Sheet is mandatory for a responsibility determination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0208

Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

in 6 days

AI Contract Overview

The contract pertains to the procurement of Hydrogen Peroxide Topical Solution, USP, at a concentration of 3% stabilized, packaged in 473-milliliter bottles (16 fluid ounces), designated by NSN 6505-00-153-8480, with a total quantity of 10 bottles. The item is intended for over-the-counter topical external use only, with clear usage restrictions prohibiting application to the eyes, large body areas, or extended use beyond one week. The solution must be stored tightly sealed at controlled room temperature, protected from freezing and excessive heat, and must not be shaken. Packaging and labeling must strictly adhere to Medical Marking Standard No. 1, superseding MIL-STD-129 for medical acquisitions, and all shipments require compliance with MIL-STD-2073-1E for preservation and packing. Each unit must be sealed within a protective container and placed in suitable commercial shipping containers to ensure safe delivery via common carrier at minimum cost to the destination point in East Greenwich, RI. The product is regulated by the FDA and classified as hazardous, requiring full compliance with OSHA’s Hazard Communication Standard (29 CFR 1910.1200) to include submission of Safety Data Sheets and compliant hazard labels prior to award, along with employee training on new labeling and documentation requirements. The contract specifies FOB Destination terms, requiring the contractor to bear all delivery costs and risks until receipt at the delivery point, with inspection and acceptance occurring at destination. The delivery schedule mandates fulfillment within 20 days after award, with no variance permitted in quantity. A shelf-life requirement of 24 months, non-extendable, applies as a Type I (Code M) item. The contract includes a suite of mandatory clauses covering equal opportunity, combating human trafficking, employment eligibility verification, sustainable products, cybersecurity safeguarding, export controls, and restrictions on telecommunications equipment from designated Chinese military companies. Electronic invoicing through Wide Area WorkFlow is required, and all offerors must provide a Unique Entity Identifier and certify their size and socioeconomic status, including any claims for small business, WOSB, HUBZone, or SDVOSB status. The solicitation, issued under SPE2DP-26-T-4574, closes on August 17, 2026, with proposals submitted exclusively via the DLA Internet Bid Board System, and all compliance documentation must be current as of

General Info

Procure 10 bottles of 3% hydrogen peroxide topical solution, FDA-regulated, 24-month shelf life, FOB destination, compliant labeling and storage.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLDG 235, EAST GREENWICH, RI, 02818-0000, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-4574 Medical Supply Chain Pharma FSA

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 9

Solicitation

Response DeadlineAug 17

Deadline has passed

Submission Closed

08/17/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Patrell Postell

contact@example.gov

Full Description

HYDROGEN PEROXIDE TOPICAL SOLUTION
Cancel all requisitions without replacement DMLIIS Request ID 1721935 has been approved by the services to change from ACC -L to ACCY. Letitia McMillan contact@example.gov
HYDROGEN PEROXIDE TOPICAL SOLUTION,USP RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. OVER THE COUNTER (OTC).. ROUTE OF ADMINISTRATION: TOPICAL. FOR
EXTERNAL USE ONLY.. DO NOT USE IN EYES OR APPLY OVER LARGE AREAS OF THE
BODY. DO NOT USE LONGER THAN 1 WEEK.. CONTAINS 3% HYDROGEN PEROXIDE
(STABILIZED) AS THE ACTIVE INGREDIENT.. UNIT OF ISSUE IS A BOTTLE
CONTAINING 473 MILLILITERS (16 FLUID OUNCES OR 1 PINT).. KEEP TIGHTLY
CLOSED AND AT CONTROLLED ROOM TEMPERATURE. DO NOT SHAKE BOTTLE. HOLD
AWAY FROM FACE WHEN OPENING. PROTECT FROM FREEZING AND AVOID EXCESSIVE
HEAT.. LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING
STANDARD NO. 1A DATED 4 FEBRUARY 2013. 11/25/2015..
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 473 ML Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
SPE2DP-26-T-4574
SECTION B
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
CARDINAL HEALTH 200, LLC 07TA6 P/N NDC3720-50871-43 MEDLINE INDUSTRIES, LP 0PMN3 P/N MDS098001H MEDLINE INDUSTRIES, LP 0PMN3 P/N NDC53329-0981-06 MCKESSON MEDICAL-SURGICAL GOVERNMENT 1EU19 P/N 142779 MCKESSON MEDICAL-SURGICAL GOVERNMENT 1EU19 P/N 23-D0012 MCKESSON MEDICAL-SURGICAL GOVERNMENT 1EU19 P/N NDC68599-2301-06
SPE2DP-26-T-4574
SECTION B
PR: 7017789583 PRLI: 0001 CONT’D
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017789583 0001 BT 10.000
NSN/MATERIAL:6505001538480
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-00-153-8480 Quantity: 10 BT Purchase Request: 7017789583QTY: 10 Delivery: 20 days ADO